CD274 and cancer: Our observation let us speculate that other immune cells expressing B7-H1 could also be modulated by sulforaphane in their phenotypes and functions, and that the use of sulforaphane in cancer patients could lead to a decrease in general immunosuppression and to an improvement of antitumor response.